
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
A study will serve as the basis for a national neuropathic pain database.
Study Type: Observational Pain
Age/gender requirements: not specified (male/female)
Sponsor: Lawson Health Research Institute
Purpose: The study will serve to establish a national neuropathic pain database and determine the long term outcome of the management of chronic neuropathic pain. The
database will provide information on demographics, diagnosis, treatment interventions and outcome.
Click






